News Home

Press Releases

Supply Update

Subscribe




Downloads
TIMELINE OF INNOVATION

CORPORATE FACT SHEET



2010 | 2009 | 2008

7/15/10 Lantheus Medical Imaging, Inc. Launches DEFINITY® Ultrasound Contrast Imaging Agent in India
7/12/10 Lantheus Medical Imaging, Inc. Purchases Balance of Worldwide Rights for MRA Imaging Agent ABLAVAR® (Gadofosveset Trisodium)
7/08/10 Lantheus Medical Imaging, Inc. Announces Agreement with MDS Nordion to Secure Additional Supply of Molybdenum-99 (Mo-99), a Key Medical Isotope
6/14/10 Lantheus Medical Imaging, Inc. Presents Phase 4 Safety Data on DEFINITY® at American Society of Echocardiography Annual Meeting
6/09/10 Lantheus Medical Imaging, Inc. Presents Preliminary Data on Novel PET Myocardial Perfusion Imaging Agent Protocol at SNM Annual Meeting
6/09/10 Lantheus Medical Imaging, Inc. Recognized as Top-Performing Supplier by Premier Purchasing Partners, L.P.
6/08/10 Lantheus Medical Imaging, Inc. Presents Phase 1 Data Highlighting Safety, Dosimetry and Tolerability of Novel PET Heart Failure Imaging Agent at SNM Annual Meeting
6/07/10 Lantheus Medical Imaging, Inc. Presents Preliminary Data Comparing Novel Cardiac PET Imaging Agent With SPECT at SNM Annual Meeting
6/03/10 Lantheus Medical Imaging, Inc. to Present at Jefferies 2010 Global Life Sciences Conference
6/03/10 Lantheus Medical Imaging, Inc. Announces Magnetic Resonance Angiography (MRA) Contract Award for ABLAVAR® With Amerinet, Inc.
5/21/10 Lantheus Medical Imaging, Inc. Announces Increased Access to Medical Isotope Molybdenum-99 From Czech Nuclear Research Institute
5/19/10 Lantheus Medical Imaging, Inc. to Present Data on Cardiovascular PET Imaging Pipeline Candidates at SNM Annual Meeting
4/22/10 Lantheus Medical Imaging, Inc. Announces Appointment of Dana S. Washburn, M.D., as Vice President, Clinical Development and Medical Affairs
3/16/10 Lantheus Medical Imaging, Inc. Presents Preliminary Phase 2 Data With Flurpiridaz F 18 (BMS747158), a Novel PET Cardiac Imaging Agent, at the American College Of Cardiology 59th Annual Scientific Session
03/09/10 Lantheus Medical Imaging, Inc. to Present New Data on Novel PET Cardiac and Heart Failure Imaging Agents at the American College of Cardiology 59th Annual Scientific Session in Atlanta
02/17/10 Lantheus Medical Imaging, Inc. Announces Appointment of Robert A. Spurr as Vice President, Sales and Marketing
01/20/10 Lantheus Medical Imaging, Inc.  Launches ABLAVAR™ (Gadofosveset Trisodium), a New Diagnostic Magnetic Resonance Angiography Agent

© 2010 Lantheus Medical Imaging, Inc.